Rhumbline Advisers Nuvectis Pharma, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$5.98 - $8.25 $33,673 - $46,455
-5,631 Reduced 75.06%
1,871 $11,000
Q1 2024

May 09, 2024
BUY
$6.69 - $11.0 $1,532 - $2,519
229 Added 3.15%
7,502 $61,000
Q3 2023

Nov 09, 2023
BUY
$12.89 - $16.29 $6,380 - $8,063
495 Added 7.3%
7,273 $93,000
Q2 2023

Aug 08, 2023
BUY
$12.62 - $18.4 $85,538 - $124,715
6,778 New
6,778 $108,000

Others Institutions Holding NVCT

# of Institutions
32
Shares Held
1.65M
Call Options Held
0
Put Options Held
0
View Full List

About Nuvectis Pharma, Inc.

NVCT Quotes by TradingView
  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $73.5M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email